When discussing hair removal options, many products promise quick fixes or a return to the hair’s original luster. Unfortunately, these claims often fall short, leading to subpar and temporary results.

Despite the fact that 80% of men experience male pattern baldness, our understanding of how to slow, halt, or even reverse this process has been limited until recently.

Fortunately, breakthroughs in science may reveal effective strategies to combat this issue.

The intriguing solution could involve freezing hair at extremely low temperatures to produce clones—yes, clones! Sci-fi enthusiasts, get ready to support this innovation.

What Causes Male Pattern Baldness?

The common misconception is that bald individuals lack hair entirely, but that’s not true. When hair is lost, it doesn’t disappear; instead, it shrinks.

“Baldness is a result of hair shrinking,” explains Paul Kemp, CEO of HairClone, a pioneering company dedicated to next-generation hair loss treatments. “The hair isn’t gone; it’s just becoming smaller and less visible.”

The shrinkage occurs due to a type of skin cell known as dermal papilla, which surrounds the base of hair follicles and is essential for hair formation, growth, and texture.

During hair loss, the number of these vital cells—typically around 1,000 per follicle—diminishes dramatically.

This loss is exacerbated by dihydrotestosterone (DHT), a potent derivative of testosterone that affects hair follicles differently across the scalp. Generally, dermal papilla cells on the top of the head are more susceptible to this process compared to those on the sides.

Recent research findings, published in Experimental Dermatology, explore how these skin cells differentiate during early embryonic development, suggesting a genetic basis for why some areas are more prone to hair loss.

“The dermal cells that are lost and those that remain originate from distinctly different populations,” Professor Kemp clarifies. “Essentially, where you experience hair loss can be likened to a ticking clock set from the moment your body begins to develop.”

Read More:

Why Cloning Hair Could Cure Baldness

With the loss of dermal papilla cells linked to baldness, researchers are racing to discover ways to replenish them. Hair cloning, also known as hair propagation, is gaining traction, thanks to frontrunners like HairClone.

This pioneering technology is not yet available in the UK or US, but if successful, it could come with a hefty price tag. Kemp notes, “While initial costs will be high, scaling up production should help lower prices, making it comparable to advanced hair transplant techniques.”

Unlike traditional hair transplants, hair cloning can be initiated before significant hair loss occurs, ensuring discreet treatment results.

Here’s how the process works:

1. Hair Root Collection and Preservation:

Healthy hair follicles are extracted from areas where hair is still growing and cryogenically preserved for later use. For optimal results, it’s crucial to gather these follicles while they are still young.

2. Cell Multiplication:

This step involves isolating and multiplying dermal papilla cells in a laboratory setting. As Dr. Jennifer Dillon states: “From one follicle, we can multiply these cells over 1,000 times, resulting in over a million cells.”

3. Replantation:

The cultivated dermal papilla cells are injected back into bald areas of the scalp, returning hair to its natural thickness and fullness. This step is awaiting regulatory approval, but initial clinical data is promising.

While banking hair follicles is currently possible globally, it comes with a significant cost.

What Other Treatments Are Available?

Although hair cloning is a buzz-worthy topic, it isn’t the sole treatment option. A study published in the Cosmetic Dermatology Journal suggests that fat cells harvested from the abdomen could regenerate hair. This method, known as autologous fat grafting (AFG), eliminates the need for cryogenic preservation.

AFG falls under stem cell therapy, using versatile cells that can transform into various cell types to meet regenerative needs. Instead of freezing hair cells, stem cells can be extracted from the patient’s body and directed to grow into hair cells, injected into the scalp just like in hair cloning.

Another innovative treatment in development is microRNA therapy, which fine-tunes gene expression to stimulate hair growth and has the potential to be applied topically, thus reducing invasiveness.

When Will These Treatments Be Available?

As with hair cloning, various stem cell and microRNA treatments are currently seeking clinical approval, potentially becoming available in the coming years. Despite the rising optimism for effective baldness treatments, Dr. Claire Higgins, a tissue regeneration expert at Imperial College London, warns that success in lab trials does not always translate to clinical effectiveness.

Dr. Higgins believes that understanding the specific reasons why some dermal papilla cells are more vulnerable to hair loss will be key in designing more effective treatments. “While we understand the physiological changes leading to hair loss, the underlying causes remain unclear.”

Optimistically, Kemp concludes that future generations will have revolutionary solutions for hair restoration, much like advancements in dentistry. “Rather than waiting for hair loss to occur, we envision a world where individuals can maintain their hair throughout life.”

About Our Experts

Dr. Paul Kemp is the Co-founder and CEO of HairClone. Previously, he led the development of the first multicellular therapy approved by the FDA, currently benefitting millions globally. He also serves as co-director for doctoral training in regenerative medicine at the University of Manchester.

Dr. Claire Higgins is a leading lecturer in Tissue Engineering and Regenerative Medicine at Imperial College London, focusing on hair follicles and skin regeneration.

Dr. Jennifer Dillon heads research at HairClone, specializing in the development of cell therapies for hair loss and possessing over a decade of experience in stem cell and cancer research.

Read More: